Status:
UNKNOWN
The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS
Lead Sponsor:
National Taiwan University Hospital
Conditions:
CAD
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This clinical trial is to test if a 28-channel ECG (MECG) system would efficiently differentiate the patients suspected to have CAD or ACS with acceptable sensitivity and specificity, and optimize thi...
Detailed Description
We shall conduct this prospective clinical study to define the specific patterns of multichannel ECG change in adults with suspected CAD or ACS. For multichannel ECG (M-ECG) examination, the signal wi...
Eligibility Criteria
Inclusion
- \>20 years
- Patients admitted for cardiac catheterization examination due to clinically suspected coronary artery disease (CAD): Those who have exertional chest pain and positive ischemic change by stress test, highly suspected lesions on non-invasive images, or very typical chest pain symptoms.
- Patients visiting ER due to suspected ACS: Those who have sudden onset of chest pain or shortness of breath.
Exclusion
- Wound over the fore chest
- Life-threatening malignancy in 5 years
- Treatment with immunosuppressive agents
- Any unfeasible condition or situation from the opinion of the primary care physicians (ex.
- critical condition needing emergency treatment or intervention, cardio pulmonary cerebral resuscitation, etc.)
Key Trial Info
Start Date :
May 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04787796
Start Date
May 14 2020
End Date
May 1 2025
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NTUH
Taipei, Taiwan, Taiwan